反応式
C1(O[C:8](=[O:28])[NH:9][C:10]2[S:14][N:13]=[C:12]([O:15][CH2:16][C:17]3[CH:22]=[CH:21][C:20]([CH3:23])=[CH:19][C:18]=3[F:24])[C:11]=2[C:25](=[O:27])[NH2:26])C=CC=CC=1.[CH:29]([NH:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][NH2:38])([CH3:31])[CH3:30]>>[F:24][C:18]1[CH:19]=[C:20]([CH3:23])[CH:21]=[CH:22][C:17]=1[CH2:16][O:15][C:12]1[C:11]([C:25]([NH2:26])=[O:27])=[C:10]([NH:9][C:8]([NH:38][CH2:37][CH2:36][CH2:35][CH2:34][CH2:33][NH:32][CH:29]([CH3:31])[CH3:30])=[O:28])[S:14][N:13]=1参加物
3
実験手順
The title compound was prepared from [4-carbamoyl-3-(2-fluoro-4-methyl-benzyloxy)-isothiazol-5-yl]-carbamic acid phenyl ester and N-isopropyl-pentane-1,5-diamine by the procedure analogous to Example 1. MS (APCI, m/z): 452 [M+H]+.
出典と根拠
- ORDレコード
- ord-bfd55c422920475e8d59016924b5da36
- 出典データセット
- uspto-grants-2010_09
- 特許番号
- US07790902B2
関連ノート
読み込み中…